These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 18308545)

  • 1. Recombinant factor VIIa for major obstetric haemorrhage in a Jehovah's Witness.
    Laird R; Carabine U
    Int J Obstet Anesth; 2008 Apr; 17(2):193-4. PubMed ID: 18308545
    [No Abstract]   [Full Text] [Related]  

  • 2. Preferences of Jehovah's Witnesses regarding haematological supports in an obstetric setting: experience of a single university teaching hospital.
    Husarova V; Donnelly G; Doolan A; Garstka M; Ni Ainle F; McCaul C
    Int J Obstet Anesth; 2016 Feb; 25():53-7. PubMed ID: 26597403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant factor VIIa in massive postpartum haemorrhage.
    Karalapillai D; Popham P
    Int J Obstet Anesth; 2007 Jan; 16(1):29-34. PubMed ID: 17125989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe gastrointestinal haemorrhage responding to recombinant factor VIIa in a Jehovah's Witness with refractory immune thrombocytopenia.
    Virchis A; Hughes C; Berney S
    Hematol J; 2004; 5(3):281-2. PubMed ID: 15167918
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of excessive bleeding in Jehovah's Witness patients after cardiac surgery with recombinant factor VIIa (NovoSeven).
    Tanaka KA; Waly AA; Cooper WA; Levy JH
    Anesthesiology; 2003 Jun; 98(6):1513-5. PubMed ID: 12766668
    [No Abstract]   [Full Text] [Related]  

  • 6. Postpartum hemorrhage in a Jehovah's Witness patient controlled with Tisseel, tranexamic acid, and recombinant factor VIIa.
    Arab TS; Al-Wazzan AB; Maslow K
    J Obstet Gynaecol Can; 2010 Oct; 32(10):984-7. PubMed ID: 21176309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of recombinant factor viia in a jehovah's witness with auto-immune thrombocytopenia and post-splenectomy haemorrhage.
    Waddington DP; McAuley FT; Hanley JP; Summerfield GP
    Br J Haematol; 2002 Oct; 119(1):286-8. PubMed ID: 12358947
    [No Abstract]   [Full Text] [Related]  

  • 8. A pregnant Jehovah's witness.
    Sheehan SR; Murphy DJ
    BMJ; 2008 Oct; 337():a1935. PubMed ID: 18923195
    [No Abstract]   [Full Text] [Related]  

  • 9. Splenic embolization in a Jehovah's Witness: role of recombinant human factor VIIa.
    Mindikoglu AL; Anantharaju A; George M; Leone N; Bejna J; Van Thiel DH
    Hepatogastroenterology; 2003; 50(53):1697-9. PubMed ID: 14571820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of recombinant activated factor VII in a Jehovah's Witness patient.
    Hsieh A; Cheong I
    Am J Emerg Med; 2007 Nov; 25(9):1085.e1-2. PubMed ID: 18022514
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of recombinant activated factor VII for reduction of perioperative blood loss during elective surgical correction of spine deformity in a Jehovah's Witness. Case report.
    Kącka K; Kącki W; Merak J; Błęka A
    Ortop Traumatol Rehabil; 2010; 12(5):448-58. PubMed ID: 21057153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coagulopathy after cardiopulmonary bypass in Jehovah's Witness patients: management of two cases using fractionated components and factor VIIa.
    Sniecinski RM; Chen EP; Levy JH; Szlam F; Tanaka KA
    Anesth Analg; 2007 Apr; 104(4):763-5. PubMed ID: 17377078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salvage for Postpartum Massive Haemorrhage in a Jehovah's Witness with Intravenous Iron Therapy and Cell Saver System.
    Sivrikoz TS; Isguder CK; Canturk MM; Sungur MO; Besisik SK
    J Coll Physicians Surg Pak; 2022 Sep; 32(9):1202-1204. PubMed ID: 36089721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caesarean section for placenta praevia complicated by postpartum haemorrhage managed successfully with recombinant activated human coagulation Factor VIIa.
    Gidiri M; Noble W; Rafique Z; Patil K; Lindow SW
    J Obstet Gynaecol; 2004 Nov; 24(8):925-6. PubMed ID: 16147656
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of recombinant factor VIIa for massive postpartum haemhorrage: case series and review of literature.
    Shamsi TS; Hossain N; Soomro N; Hasan JA; Noorani M; Kazi S; Quraishy MS; Jameel B; Sultan ST; Haider S
    J Pak Med Assoc; 2005 Nov; 55(11):512-5. PubMed ID: 16304877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary embolism after administration of recombinant activated Factor VII for major obstetric hemorrhage.
    McCarthy GC; Allen TK; Habib AS
    J Clin Anesth; 2012 Sep; 24(6):508-9. PubMed ID: 22986324
    [No Abstract]   [Full Text] [Related]  

  • 17. Mortality risk stratification in severely anaemic Jehovah's Witness patients.
    Beliaev AM; Marshall RJ; Smith W; Windsor JA
    Intern Med J; 2012 Mar; 42(3):e1-3. PubMed ID: 22432994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnancy-associated breast cancer: a review for the obstetrical care provider.
    Somerset D
    J Obstet Gynaecol Can; 2011 Sep; 33(9):897-898. PubMed ID: 21923985
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful treatment of intestinal hemorrhage in a Jehovah's Witness patient.
    Veneri D; Franchini M
    Am J Hematol; 2005 Aug; 79(4):344-5. PubMed ID: 16044447
    [No Abstract]   [Full Text] [Related]  

  • 20. [Obstetric Surgery with High Risk of Postpartum Hemorrhage in a Jehovah's Witness].
    Carp M; Maurício S; Lança F
    Acta Med Port; 2021 Mar; 34(4):300-303. PubMed ID: 34214421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.